Physician profile
Michael Cohn
NPI 1952389843
$1,231.74
in general payments reported to CMS, 2019-2025
8 companies · $216 in 2025
The $216 reported for 2025 was more than what 80% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.30 · 2020: $478 · 2021: $38.39 · 2022: $74.99 · 2023: $309 · 2024: $91.80 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argon Medical Devices, INC. | $406.38 | 2019-2025 | Clot Management |
| Sirtex Medical INC | $346.08 | 2020-2023 | Sir-Spheres Microspheres |
| Boston Scientific Corporation | $151.38 | 2020-2024 | |
| Inari Medical, INC. | $121.12 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Siemens Medical Solutions USA, INC. | $100.18 | 2020-2022 | |
| Trisalus Life Sciences, INC. | $60.31 | 2024 | Trinav Infusion System |
| Myriad Genetic Laboratories, INC. | $29.89 | 2023 | Myrisk |
| Bard Peripheral Vascular, INC. | $16.40 | 2023 | Powerport M.R.I. Implantable Port |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.